Table of Contents

company-logo

Genomtec S.A. researches, develops, manufactures, and commercializes innovative molecular diagnostic products in optical systems and isothermal nucleic acid amplification methods in Poland and internationally. The company develops Genomtec ID, a technological device that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analyzing the biological material of patients using swabs, urine samples, saliva, blood, and other body fluids. It also develops Genomtec Tumor, a SNAAT based solution used to identify neoplastic mutations and mutations with prognostic value in neoplastic disease; Genomtec SARS-CoV-2 EvaGreen and Direct-RT-LAMP CE-IVD Kit to detect SARS-CoV-2 RNA in various biological samples from patients with suspected COVID-19 infection; and Genomtec RT-LAMP CE-IVD Duo-Kit for the detection of all variants of the SARS-CoV-2 virus. Genomtec S.A was founded in 2016 and is based in Wroclaw, Poland.

Genomtec Dividend Announcement

• Genomtec does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Genomtec dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Genomtec Dividend History

Genomtec Dividend Yield

Genomtec current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Genomtec stock? Use our calculator to estimate your expected dividend yield:

Genomtec Financial Ratios

P/E ratio-8.57
PEG ratio-0.09
P/B ratio7.38
ROE-118.19%
Payout ratio0.00%
Current ratio2.03
Quick ratio1.45
Cash Ratio1.22

Genomtec Dividend FAQ

Does Genomtec stock pay dividends?
Genomtec does not currently pay dividends to its shareholders.
Has Genomtec ever paid a dividend?
No, Genomtec has no a history of paying dividends to its shareholders. Genomtec is not known for its dividend payments.
Why doesn't Genomtec pay dividends?
There are several potential reasons why Genomtec would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Genomtec ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Genomtec has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Genomtec a dividend aristocrat?
Genomtec is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Genomtec a dividend king?
Genomtec is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Genomtec a dividend stock?
No, Genomtec is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Genomtec stocks?
To buy Genomtec you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Genomtec stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.